IUCRO-0049; Immunological Genetic Molecular and pathological Correlates with Clinical and Treatment Outcome in Patients With Renal Cell Carcinoma

Overview

The major purposes of this research study is to obtain blood and tissue samples from patients diagnosed with kidney cancer and/or tissue samples from patients undergoing surgery for their kidney cancer and to obtain clinical information.

Description

The major purposes of this research study is to obtain blood and tissue samples from patients diagnosed with kidney cancer and/or tissue samples from patients undergoing surgery for their kidney cancer and to obtain clinical information.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions: Renal Cell Carcinoma
  • Age: Between 18 Years - 100 Years
  • Gender: Male or Female

Inclusion Criteria
Patients must have documented or suspected renal cell cancer.


Additional Information:
Participants will not be paid for their participation.

Updated on 20 Nov 2022 . Study ID: TX1001

Connect with a study center near you

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center